Edoxaban in Atrial Fibrillation and Venous Thromboembolism—Ten Key Questions and Answers: A Practical Guide

Edoxaban is the fourth non-vitamin K antagonist oral anticoagulant now available for clinical use in the prevention of stroke/systemic embolism in atrial fibrillation (AF) and in the treatment of venous thromboembolism (VTE), after the completion of large-scale randomized comparative clinical trials...

詳細記述

保存先:
書誌詳細
出版年:Adv Ther
主要な著者: De Caterina, Raffaele, Ageno, Walter, Boriani, Giuseppe, Colonna, Paolo, Ghirarduzzi, Angelo, Patti, Giuseppe, Rossini, Roberta, Rubboli, Andrea, Schinco, Piercarla, Agnelli, Giancarlo
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2017
主題:
Review
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5350200/
https://ncbi.nlm.nih.gov/pubmed/28194578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-017-0488-9
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料